We are a group of statisticians working at CROs and pharmaceutical industry supporting preclinical drug discovery on animal and cell based experiments. As a group, our focus is on diverse range of preclinical topics such as;
We organise webinars and workshops on topics and methodological developments in preclinical research and now have a list of over 50 affiliates on our e-mail distribution list.
Core Committee (L-R):
| Name | Company/Institution |
| Denise Federico | Evotec |
| Luc Essermeant | Sanofi |
| Eloisa Brook | GSK (chair) |
| Dorothee Tamarelle | Sanofi |
| Fetene Tekle | Janssen |
| Bernd Igl | Boehringer Ingelheim |
| Ezgi Tanriver-Ayder | GSK |
| Sarah Vandepaer | GSK |
We see our mission as bridging preclinical knowledge and expertise within the pharmaceutical industry and academia to provide a forum to collaborate, discuss and advance statistical topics related to Research, Discovery (including efficacy models), Regulatory and Investigative Toxicology/Safety Assessment. We also hope to encourage the development of relevant statistical methodologies and promote the involvement of statisticians in these areas.
Find out more about us and our objectives in our video overview:
PSI Pre-clinical Special Interest Group have a
series of regular FREE webinars dealing with statistical topics faced in
pre-clinical and related fields. The presentations will run for an hour, with
approximately 45 min presentation and a Q&A session in the remaining time.
See section below for details of this year’s webinars. Please note that
these events take place online via Zoom, and have a limited number of places
available.
The PSI Pre-Clinical Special Interest Group seminars for 2024 are as follows:
Date | Title | Presenter | |
26 March 2024 | Mixed-Level OMARS Designs for Quantitative and Categorical Factors: Theory and Application | Professor Peter Goos, KU Leuven | To access video on demand, click here |
We held our first face-to-face workshop since 2019 in Paris this year. It was wonderful to connect with old and new faces.There was great engagement in the sessions; we all learnt something and had fun too!
Day | Title | Presenter(s) |
1 | Application of experimental design in animal research: theory and practice | Simon Bate, GSK |
| 2 | Analysing Pre-clinical experiments | Odile Coudert, Ipsen & Bernard Franq, GSK |
| Statistics in Toxicology | Philip Jarvis, Novartis & David Lovell, University of London |
Please email us if you are interested in contributing to PSI Preclinical SIG or would like to join our mailing list.
